PanGen Biotech Inc. (KOSDAQ:222110)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,070.00
+180.00 (3.06%)
At close: Dec 5, 2025
21.40%
Market Cap 81.91B
Revenue (ttm) 15.27B
Net Income (ttm) 1.64B
Shares Out 13.49M
EPS (ttm) 126.74
PE Ratio 47.89
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,024
Average Volume 15,703
Open 5,900.00
Previous Close 5,890.00
Day's Range 5,790.00 - 6,100.00
52-Week Range 4,305.00 - 7,400.00
Beta -0.13
RSI 59.38
Earnings Date n/a

About PanGen Biotech

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 222110
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.